No Data
No Data
Express News | Nanovibronix Announces Commencement of Uroshield Clinical Study at the University of Michigan
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, "Entering into the pilot phase of the UroShield study at the University of Michigan is an important step towards our goal of applying for permanent FDA clearance or approval for the UroShield product.
NanoVibronix Shares Q1 2024 Performance and Business Update
Express News | NanoVibronix Q1 EPS $(0.23) Up From $(0.67) YoY, Sales $921.00K Up From $354.00K YoY
NanoVibronix | 10-Q: Quarterly report
Express News | Nanovibronix- Under Terms of Multi-Year Deal, CB Medical Has Right to Sell and Distribute Uroshield to Its Customers Throughout Va System in US
No Data